1. Home
  2. AMPG vs SAVA Comparison

AMPG vs SAVA Comparison

Compare AMPG & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPG
  • SAVA
  • Stock Information
  • Founded
  • AMPG 2002
  • SAVA 1998
  • Country
  • AMPG United States
  • SAVA United States
  • Employees
  • AMPG N/A
  • SAVA N/A
  • Industry
  • AMPG Telecommunications Equipment
  • SAVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMPG Telecommunications
  • SAVA Health Care
  • Exchange
  • AMPG Nasdaq
  • SAVA Nasdaq
  • Market Cap
  • AMPG 93.8M
  • SAVA 102.4M
  • IPO Year
  • AMPG N/A
  • SAVA N/A
  • Fundamental
  • Price
  • AMPG $4.32
  • SAVA $3.63
  • Analyst Decision
  • AMPG
  • SAVA Hold
  • Analyst Count
  • AMPG 0
  • SAVA 1
  • Target Price
  • AMPG N/A
  • SAVA $2.00
  • AVG Volume (30 Days)
  • AMPG 673.0K
  • SAVA 4.9M
  • Earning Date
  • AMPG 11-13-2025
  • SAVA 11-06-2025
  • Dividend Yield
  • AMPG N/A
  • SAVA N/A
  • EPS Growth
  • AMPG N/A
  • SAVA N/A
  • EPS
  • AMPG N/A
  • SAVA N/A
  • Revenue
  • AMPG $19,312,625.00
  • SAVA N/A
  • Revenue This Year
  • AMPG $157.46
  • SAVA N/A
  • Revenue Next Year
  • AMPG $33.33
  • SAVA N/A
  • P/E Ratio
  • AMPG N/A
  • SAVA N/A
  • Revenue Growth
  • AMPG 58.04
  • SAVA N/A
  • 52 Week Low
  • AMPG $0.70
  • SAVA $1.15
  • 52 Week High
  • AMPG $6.43
  • SAVA $33.98
  • Technical
  • Relative Strength Index (RSI)
  • AMPG 57.60
  • SAVA 72.05
  • Support Level
  • AMPG $3.78
  • SAVA $2.85
  • Resistance Level
  • AMPG $4.07
  • SAVA $3.66
  • Average True Range (ATR)
  • AMPG 0.34
  • SAVA 0.34
  • MACD
  • AMPG -0.03
  • SAVA 0.10
  • Stochastic Oscillator
  • AMPG 48.65
  • SAVA 92.90

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: